Acronym
|
Definition
|
AB |
Able-bodied |
AFF |
Atypical Femoral Fracture |
AIS |
ASIA Impairment Scale |
ASIA |
American Spinal Cord Injury Association |
BMD |
Bone Mineral Density |
CI |
Confidence Interval |
CPG |
Clinical Practice Guideline |
CTX-1 |
C-terminal Cross-linking Telopeptide of Type I Collagen |
DXA |
Dual Energy X-ray Absorptiometry |
DF |
Distal Femur |
FES |
Functional Electrical Stimulation |
FSH |
Follicle-Stimulating Hormone |
HR |
Hazard Ratio |
IGF-1 |
Insulin-like Growth Factor 1 |
IV |
Intravenous |
LH |
Luteinizing Hormone |
NMES |
Neuromuscular Electrical Stimulation |
NTX-1 |
N-terminal Cross-linking Telopeptide of Type I Collagen |
OC |
Osteocalcin |
ONJ |
Osteonecrosis of the Jaw |
OPG |
Osteoprotegerin |
ORIF |
Open Reduction with Internal Fixation |
PTH |
Parathryroid Hormone |
P1NP |
Procollagen 1 Intact N-Terminal Propeptide |
pQCT |
Peripheral Quantitative Computed Tomography |
PT |
Proximal Tibia |
PVA |
Paralyzed Veterans of America |
RANKL |
Receptor Activator of Nuclear factor kappa-Β Ligand |
SCI |
Spinal Cord Injury |
SCI/D |
Spinal Cord Injury/Disease |
ZA |
Zolendronic Acid |